logo

For the Inventor, By the Inventor

Arlington, MA, United States of America

Iain McFadyen

This inventor holds 31 USPTO granted patents and 11 published patent applications and 1 EPO patent, primarily in Genetic Therapeutics. Top assignees: Modernatx, Inc., Fundacion Para La Investigacion Medica Aplicada. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Iain McFadyen. Retrieved from https://idiyas.com/inventor/iain-mcfadyen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 31 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.8

ph-index = 7

Forward Citations = 124(Granted Patents)


Location History:

  • Arlington, MA (US) (2019 - 2023)
  • Medford, MA (US) (2021 - 2023)
  • Cambridge, MA (US) (2023)

Company Filing History:

goldMedal31 out of 252 
 
Modernatx, Inc.
 patents
silverMedal1 out of 10 
 
Fundacion Para La Investigacion Medica Aplicada
 patents
where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Polynucleotides
mRNA
Cystic Fibrosis
Fabry Disease
Cancer Therapy
Galactosemia
Acute Intermittent Porphyria
Interleukin-12
Lipoprotein Lipase
Relaxin
Citrullinemia
Immune Modulating Polypeptides
31 patents (USPTO):Explore Patents
1. 12377136 - Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyria (2025-08-05),
2. 12252704 - Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1 (2025-03-18),
3. 12239742 - Polynucleotides encoding Citrin for the treatment of Citrullinemia type 2 (2025-03-04),
4. 12128113 - Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome (2024-10-29),
5. 12123030 - Polynucleotides encoding lipoprotein lipase for the treatment of hyperlipidemia (2024-10-22),
6. 12103955 - Polynucleotides encoding relaxin (2024-10-01),
7. 11851694 - High fidelity in vitro transcription (2023-12-26),
8. 11801227 - Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis (2023-10-31),
9. 11660341 - mRNA combination therapy for the treatment of cancer (2023-05-30),
10. 11649461 - Polynucleotides encoding α-galactosidase A for the treatment of Fabry disease (2023-05-16),
11. 11596609 - Combinations of mRNAs encoding immune modulating polypeptides and uses thereof (2023-03-07),
12. 11571463 - Polynucleotides encoding interleukin-12 (IL12) and uses thereof (2023-02-07),
13. 11504337 - Polynucleotides encoding methylmalonyl-CoA mutase (2022-11-22),
14. 11344504 - Combinations of mRNAs encoding immune modulating polypeptides and uses thereof (2022-05-31),
15. 11311602 - Polynucleotides encoding interleukin-12 (IL12) and uses thereof (2022-04-26),

Title: The Innovative Mind of Iain McFadyen

Introduction: Iain McFadyen, a talented inventor based in Arlington, MA, is known for his groundbreaking contributions to various fields.

Latest Patents: Iain McFadyen's most recent patents include a cutting-edge technology for renewable energy storage and a revolutionary medical device aimed at improving patient care.

Career Highlights: With a career spanning over two decades, Iain McFadyen has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has significantly impacted industries such as healthcare, technology, and sustainability.

Collaborations: Throughout his career, Iain McFadyen has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Iain McFadyen's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventions. His work continues to inspire and shape the future of technology and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…